• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[白介素干扰素在胸部创伤患者化脓性并发症预防中的应用]

[Use of leukinferon for prophylaxis of pyogenic complications in victims with thoracic wounds].

作者信息

Bulava G V, Abakumov M M, Druzenko O A, Markova O A, Pogodina A N, Khvatov V B

出版信息

Khirurgiia (Mosk). 1999(7):35-9.

PMID:10459185
Abstract

The results of treatment of 131 victims with penetrating wounds of the thorax complicated by profuse bleeding, are presented. 36 of them after surgery to prevent pyogenous complications received 5 injections of leukinferon (test group); 95 patients who were not treated by leukinferon made up control group comparable with the test group by sex, age and character of wounds. Comparative analysis of the results showed that treatment with leukinferon has resulted in decrease of postoperative complications. In the test group the number of complications made up 47.2%, in control group--61%. Al the same time in the former group there was only one pyogenous complication (2.9%), while in control group--10 (10.6%). After the course of leukinferon leucocytic formula of the blood has become normal, the number of patients with immunodeficiency and imbalance of proteins markers of the acuteness of inflammatory process has decreased.

摘要

本文介绍了131例胸部穿透伤并伴有大量出血患者的治疗结果。其中36例患者术后为预防化脓性并发症接受了5次白细胞干扰素注射(试验组);95例未接受白细胞干扰素治疗的患者组成对照组,该组在性别、年龄和伤口特征方面与试验组具有可比性。结果的对比分析表明,白细胞干扰素治疗可减少术后并发症。试验组并发症发生率为47.2%,对照组为61%。同时,试验组仅出现1例化脓性并发症(2.9%),而对照组有10例(10.6%)。经过白细胞干扰素疗程后,血液白细胞计数恢复正常,免疫缺陷患者数量以及炎症过程急性期蛋白质标志物失衡情况有所减少。

相似文献

1
[Use of leukinferon for prophylaxis of pyogenic complications in victims with thoracic wounds].[白介素干扰素在胸部创伤患者化脓性并发症预防中的应用]
Khirurgiia (Mosk). 1999(7):35-9.
2
[Immunoprophylaxis of postoperative inflammatory complications in thoracic and abdominal wounds].[胸腹部伤口术后炎症并发症的免疫预防]
Khirurgiia (Mosk). 2002(7):4-10.
3
[Leukinferon in the treatment of patients with acute viral hepatitis b].[白细胞干扰素治疗急性乙型病毒性肝炎患者]
Klin Med (Mosk). 1994;72(3):27-9.
4
[Leukinferon immunomodulation in pulmonary tuberculosis].[白细胞干扰素在肺结核中的免疫调节作用]
Probl Tuberk Bolezn Legk. 2004(11):47-50.
5
[Experience of immunotherapy with leukinferon in the comprehensive therapy of breast cancer].[白细胞干扰素免疫疗法在乳腺癌综合治疗中的经验]
Vopr Onkol. 1994;40(7-12):309-13.
6
[The use of leukinferon in treating measles in adult patients].[白细胞干扰素在成年麻疹患者治疗中的应用]
Stomatologiia (Mosk). 1995;74(3):32-5.
7
[The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection].[采用白细胞干扰素免疫纠正疗法治疗淋病衣原体性泌尿生殖系统感染患者]
Ter Arkh. 1993;65(11):39-42.
8
[The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis].[白细胞干扰素治疗急性化脓性肾盂肾炎患者的临床免疫学效应]
Urol Nefrol (Mosk). 1994 May-Jun(3):8-11.
9
[Treatment of thorax wounds].[胸部伤口的治疗]
Khirurgiia (Mosk). 2007(5):32-8.
10
[Causes of complications in penetrating chest wounds].
Vestn Khir Im I I Grek. 1985 Apr;134(4):74-7.